XML 37 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 147.8 |  |  | $ | 114.7 |  |  | $ | 435.6 |  |  | $ | 347.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (38.9) |  |  | (28.1) |  |  | (97.6) |  |  | (79.5) |
Less: Income allocated to participating securities | (0.7) |  |  | (0.6) |  |  | (2.0) |  |  | (1.8) |
Income from continuing operations attributable to Encompass Health common shareholders | 108.2 |  |  | 86.0 |  |  | 336.0 |  |  | 266.1 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.7) |  |  | (1.3) |  |  | (3.2) |  |  | (3.5) |
Net income attributable to Encompass Health common shareholders | $ | 107.5 |  |  | $ | 84.7 |  |  | $ | 332.8 |  |  | $ | 262.6 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 99.9 |  |  | 99.5 |  |  | 99.9 |  |  | 99.5 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.09 |  |  | $ | 0.86 |  |  | $ | 3.36 |  |  | $ | 2.68 |
Discontinued operations | (0.01) |  |  | (0.01) |  |  | (0.03) |  |  | (0.04) |
Net income | $ | 1.08 |  |  | $ | 0.85 |  |  | $ | 3.33 |  |  | $ | 2.64 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 147.8 |  |  | $ | 114.7 |  |  | $ | 435.6 |  |  | $ | 347.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (38.9) |  |  | (28.1) |  |  | (97.6) |  |  | (79.5) |
Income from continuing operations attributable to Encompass Health common shareholders | 108.9 |  |  | 86.6 |  |  | 338.0 |  |  | 267.9 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.7) |  |  | (1.3) |  |  | (3.2) |  |  | (3.5) |
Net income attributable to Encompass Health common shareholders | $ | 108.2 |  |  | $ | 85.3 |  |  | $ | 334.8 |  |  | $ | 264.4 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 102.1 |  |  | 101.4 |  |  | 102.2 |  |  | 101.1 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.07 |  |  | $ | 0.85 |  |  | $ | 3.31 |  |  | $ | 2.65 |
Discontinued operations | (0.01) |  |  | (0.01) |  |  | (0.03) |  |  | (0.03) |
Net income | $ | 1.06 |  |  | $ | 0.84 |  |  | $ | 3.28 |  |  | $ | 2.62 |
Schedule of Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Basic weighted average common shares outstanding | 99.9 |  |  | 99.5 |  |  | 99.9 |  |  | 99.5 |
Restricted stock awards, dilutive stock options, and restricted stock units | 2.2 |  |  | 1.9 |  |  | 2.3 |  |  | 1.6 |
Diluted weighted average common shares outstanding | 102.1 |  |  | 101.4 |  |  | 102.2 |  |  | 101.1 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration